Clinical Trials Directory

Trials / Completed

CompletedNCT05328362

CanCope: Digital Intervention for Coping With Cannabis Craving

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
53 (actual)
Sponsor
Trustees of Dartmouth College · Academic / Other
Sex
All
Age
19 Years – 25 Years
Healthy volunteers
Not accepted

Summary

The CanCope Study is a micro-randomized trial conducted to gather evidence about and compare the effectiveness of a momentary intervention to help young adults cope with cannabis cravings as they attempt to reduce their use.

Detailed description

The CanCope Study is designed to test the effectiveness of two distinct strategies (mindfulness and distraction) to cope with cannabis cravings in young adults (19 - 25 years) who are attempting to reduce their cannabis use. Cannabis use is determined using a single-item question about the number of days out of the past 30 days the individual used cannabis. Young adults who reported using cannabis \>10 out of the past 30 days, who were not pregnant or breastfeeding, and who were not currently in treatment for problems related to substance use were eligible to enroll in this four-week study. The CanCope intervention was delivered to participants through the MetricWire app, which was available for download on the participants' personal smartphones. Participants were asked to complete five ecological momentary assessments (EMA) per day, which asked questions related to cannabis use including one question about current level of craving on a scale of 0 - 10. If a participant reported a craving level \>4, a message was sent via the app encouraging the participant to try a mindfulness or distraction coping strategy, or the participant received a thank-you for completing the EMA which served as an attention control.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCanCopeMessages prompted participants to use mindfulness-based or distraction-based coping strategies, or a thank-you message which served as an attention control. If participants reported elevated craving (4 or greater) prior to a decision point, they received either a coping strategy message or a control message. If participants reported craving levels of less than 4 they received a control message.

Timeline

Start date
2021-08-27
Primary completion
2021-12-16
Completion
2021-12-16
First posted
2022-04-14
Last updated
2025-01-22
Results posted
2025-01-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05328362. Inclusion in this directory is not an endorsement.